113 related articles for article (PubMed ID: 7104971)
21. Monitoring the course of cervical carcinoma with the squamous cell carcinoma serum radioimmunoassay.
Holloway RW; To A; Moradi M; Boots L; Watson N; Shingleton HM
Obstet Gynecol; 1989 Dec; 74(6):944-9. PubMed ID: 2586961
[TBL] [Abstract][Full Text] [Related]
22. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer.
Esajas MD; Duk JM; de Bruijn HW; Aalders JG; Willemse PH; Sluiter W; Pras B; ten Hoor K; Hollema H; van der Zee AG
J Clin Oncol; 2001 Oct; 19(19):3960-6. PubMed ID: 11579117
[TBL] [Abstract][Full Text] [Related]
23. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma.
Kato H; Torigoe T
Cancer; 1977 Oct; 40(4):1621-8. PubMed ID: 332328
[TBL] [Abstract][Full Text] [Related]
24. Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer.
Scambia G; Benedetti Panici P; Foti E; Amoroso M; Salerno G; Ferrandina G; Battaglia F; Greggi S; De Gaetano A; Puglia G
J Clin Oncol; 1994 Nov; 12(11):2309-16. PubMed ID: 7964945
[TBL] [Abstract][Full Text] [Related]
25. Squamous cell carcinoma (SCC) antigen in patients with invasive cervical carcinoma during primary irradiation.
Neunteufel W; Tatra G; Bieglmayer C
Gynecol Obstet Invest; 1990; 29(2):154-7. PubMed ID: 2335313
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of the relationship between clinicopathological features and pelvic lymph node metastasis in patients with early stage squamous cell carcinoma of the uterine cervix].
Tian QF; Wang XY; Lü WG; Ye F; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):760-3. PubMed ID: 19087544
[TBL] [Abstract][Full Text] [Related]
27. Squamous cell carcinoma antigen in patients with cancer of the uterine cervix.
Fuith LC; Daxenbichler G
Gynecol Obstet Invest; 1988; 26(1):77-82. PubMed ID: 3169633
[TBL] [Abstract][Full Text] [Related]
28. [Clinical value of SCC-antigen, a subfraction of tumor antigen TA-4, in the management of cervical cancer].
Kato H; Tamai K; Magaya T; Nagai M; Noguchi H; Suehiro Y; Torigoe T
Gan No Rinsho; 1985 May; 31(6 Suppl):594-9. PubMed ID: 4032751
[TBL] [Abstract][Full Text] [Related]
29. Production of tumor-associated antigen, TA-4, by the CaSki cervical carcinoma cell line.
Hussa RO; Maruo T; Strobel JL; Pattillo RA; Mochizuki M
Obstet Gynecol; 1986 Jun; 67(6):802-5. PubMed ID: 2422615
[TBL] [Abstract][Full Text] [Related]
30. Flow cytometric analysis of tumor antigen TA-4 in cervical cytologic specimens.
Suehiro Y; Kato H; Nagai M; Torigoe T
Cancer; 1986 Apr; 57(7):1380-4. PubMed ID: 2418939
[TBL] [Abstract][Full Text] [Related]
31. Elevated levels of squamous cell carcinoma antigen in patients with a benign disease of the skin.
Duk JM; van Voorst Vader PC; ten Hoor KA; Hollema H; Doeglas HM; de Bruijn HW
Cancer; 1989 Oct; 64(8):1652-6. PubMed ID: 2790678
[TBL] [Abstract][Full Text] [Related]
32. Availability of tumor-antigen 4 as a marker of squamous cell carcinoma of the lung and other organs.
Mino N; Iio A; Hamamoto K
Cancer; 1988 Aug; 62(4):730-4. PubMed ID: 2840187
[TBL] [Abstract][Full Text] [Related]
33. [Value of the assay of squamous cell carcinoma in cancer of the uterine cervix].
Gosselin P; Cazin JL; Dehaut JP; Sulman C; Baranzelli MC; Demaille MC
Presse Med; 1987 Oct; 16(34):1677-9. PubMed ID: 2959941
[TBL] [Abstract][Full Text] [Related]
34. [Immunohistological evaluation of the cancer associate antigen (TA-4) for pathoclinical management of the cervical malignancy].
Kimura A; Shibata K; Hoshina M; Maruo T; Mochizuki M
Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2248-54. PubMed ID: 6533207
[No Abstract] [Full Text] [Related]
35. Solitary recurrent metastasis of squamous cell carcinoma of the uterine cervix in the spleen: case report.
Pang LC
South Med J; 2004 Mar; 97(3):301-4. PubMed ID: 15043342
[TBL] [Abstract][Full Text] [Related]
36. Early predicting recurrent cervical cancer with combination of tissue polypeptide specific antigen (TPS) and squamous cell carcinoma antigen (SCC).
Hung YC; Shiau YC; Chang WC; Kao CH; Lin CC
Neoplasma; 2002; 49(6):415-7. PubMed ID: 12584591
[TBL] [Abstract][Full Text] [Related]
37. [Determination of the SCC antigen in the serum of patients with cervical cancer].
Crombach G; Würz H; Bolte A
Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):439-45. PubMed ID: 3623046
[TBL] [Abstract][Full Text] [Related]
38. Relationship between squamous cell carcinoma antigen levels and tumor volumes in patients with cervical carcinomas undergoing neoadjuvant chemotherapy.
Kim BG; Kim JH; Park SY; Lee JH; Lee ED; Lee KH; Park KB; Lee BH; Kim KH
Gynecol Oncol; 1996 Oct; 63(1):105-13. PubMed ID: 8898178
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
40. Evaluation of the effects of type II radical hysterectomy in the treatment of 960 patients with stage IB-IIB cervical carcinoma: A retrospective study.
Zheng M; Huang L; He L; Ding H; Wang HY; Zheng LM
J Surg Oncol; 2011 Apr; 103(5):435-41. PubMed ID: 21400530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
